Presentations and management of different causes of chylothorax in children: one medical center's experience

Chien-Heng Lin1, Wei-Ching Lin2, Jeng-Sheng Chang3

  • 1Division of Pediatric Pulmonology, China Medical University Children's Hospital, Taichung 404, Taiwan - Department of Biomedical Imaging and Radiological Science, College of Health Care to College of Medicine, China Medical University, Taichung 404, Taiwan.

Biomedicine
|May 6, 2017
PubMed

Insights

Pediatric chylothorax is most often caused by cardiothoracic surgery. Treatment with medication and chest tube drainage is effective for most children, but early intervention is key.

Area of Science:

  • Pediatric Medicine
  • Thoracic Surgery
  • Critical Care

Background:

  • Chylothorax is a rare cause of pleural effusion in children.
  • It is a frequent complication following cardiothoracic surgery.
  • Unlike adults, trauma and malignancy are uncommon causes in pediatric patients.

Purpose of the Study:

  • To investigate the various etiologies of chylothorax in pediatric patients.
  • To analyze treatment outcomes for pediatric chylothorax.
  • To identify risk factors and effective management strategies for pediatric chylothorax.

Main Methods:

  • Retrospective review of medical records.
  • Study included pediatric patients diagnosed with chylothorax between 1995 and 2005.
  • Analysis of patient demographics, etiologies, treatments, and outcomes.

Main Results:

  • Cardiothoracic surgery was the leading cause (63.6%) of chylothorax in 22 pediatric patients.
  • Congenital causes accounted for 22.7%, neuroblastoma for 9.1%, and nephrotic syndrome for 4.6%.
  • Chest tube drainage was required for 90.9%, surgical intervention for 13.6%, and mortality was 18.2% due to other causes.

Conclusions:

  • Cardiothoracic surgery is the predominant etiology of pediatric chylothorax.
  • Medical therapy and chest tube drainage are effective treatments for most cases.
  • Early recognition and timely intervention, including surgery when necessary, are crucial for optimal outcomes.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.2K
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.7K
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
855
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
755
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.8K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
916